Company intelligence / Profile preview

NeoMPS

San Diego, California, United Statespolypeptide.com ↗

Ownership: Private
Development stage: Other

Overview

NeoMPS was one of the world’s largest independent contract manufacturers of custom research and pharmaceutical-grade peptides. It provided GMP and non-GMP manufacturing services for research through commercial scale. The company also offered anti-peptide antibodies, bioactive peptides, modified amino acids, peptide building blocks, turn mimics, cosmetic peptides, radio-labeled peptides and an extensive catalog business. In November 2007 it was acquired by PolyPeptide Laboratories Group to expand their global manufacturing capacity[1][2][3][4][5][6].

Modalities: PeptidesBioactive peptidesModified amino acids (as building blocks for peptides)Small molecule derivatives (peptide building blocks)Cosmetic peptides
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on NeoMPS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeoMPS.

Explore the full profile